Form 8-K - Current report:
SEC Accession No. 0001493152-24-024720
Filing Date
2024-06-21
Accepted
2024-06-21 16:07:02
Documents
13
Period of Report
2024-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 33174
  Complete submission text file 0001493152-24-024720.txt   203084

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE eltp-20240617.xsd EX-101.SCH 3024
3 XBRL LABEL FILE eltp-20240617_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE eltp-20240617_pre.xml EX-101.PRE 22365
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3470
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NJ | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-15697 | Film No.: 241060210
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)